Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8852447
Porous nanostructures and methods involving the same
granted -
US 8846629
Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma
granted -
US 8846697
Purine analogs
granted -
US 8846066
Methods and related compositions for reduction of fat and skin tightening
granted -
US 8846866
Aldehyde tags, uses thereof in site-specific protein modification
granted -
US 8846770
Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
granted -
US 8846643
Phosphonates with reduced toxicity for treatment of viral infections
granted -
US 8841350
Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
granted -
US 8841258
Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation
granted -
US 8834896
Vault compositions for immunization
granted -
US 8835630
Acyclic nucleoside phosphonate diesters
granted -
US 8835166
Extracellular matrix material created using non-thermal irreversible electroporation
granted -
US 8835386
Activity of recombinant equine follicle stimulating hormone
granted -
US 8828980
Controlled release corticosteroid compositions and methods for the treatment of otic disorders
granted -
US 8828383
Nanocarriers with multi-photon response elements
granted -
US 8828652
Elimination of N-glycolylneuraminic acid from animal products for human use
granted -
US 8821884
Compositions and methods using MD-2 mutants and chimeric proteins
granted -
US 8815885
Methods and compositions for modulating IRE1, SRC, and ABL activity
granted -
US 8815951
Inhibitors of epoxide hydrolases for the treatment of inflammation
granted -
US 8808698
Methods for inhibition of lymphangiogenesis and tumor metastasis
granted -
US 8809268
Combination therapy to combat helminth resistance
granted -
US 8809291
Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
granted -
US 8802689
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
granted -
US 8796233
Methods and systems for modulating hormones and related methods, agents and compositions
granted